Effects of Estriol-Lactobacilli Combination Versus Polycarbophil-Based Vaginal Moisturizer on Post-Radiation Vaginitis in Women With Cervical Cancer: A Randomized Controlled Trial.
Natcha Koohachaiskun, Thiti Atjimakul, Krantarat Peeyananjarassri et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial evaluated the efficacy of an estriol-lactobacilli combination vaginal tablet (E3/L) versus a polycarbophil-based vaginal moisturizer (PBVM) in 34 women with post-radiation vaginitis after cervical cancer treatment. E3/L resulted in a significantly greater median improvement in vaginal maturation value (19.65 vs. 2.08 points; p = 0.035).
Key findings
- E3/L showed a median improvement in vaginal maturation value of 19.65 points compared to 2.08 points for PBVM (p = 0.035).
- Significant improvements in vaginal dryness and inflammation were observed in the E3/L group.
- The change in Female Sexual Function Index scores was greater with E3/L (+6 vs. +2; p = 0.01).
Why it matters
The study highlights a potential therapeutic option for managing post-radiation vaginitis in cervical cancer patients, addressing significant symptoms like vaginal dryness and inflammation, which can impact quality of life.
What to keep in mind
The study's limitations include a modest sample size, open-label design, and short follow-up duration.